We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$127B
1-Year Est. Return
46.06%
This Fund
S&P 500
This Quarter
Est. Return
+4.99%
1 Year Est. Return
+46.06%
3 Year Est. Return
+142.12%
5 Year Est. Return
+190.33%
10 Year Est. Return
+788.65%
AUM
$110B
AUM Growth
+$11.3B
(+11%)
Cap. Flow
+$8.89B
Cap. Flow
% of AUM
8.09%
Top 10 Holdings %
Top 10 Hldgs %
35.27%
Holding
3,643
New
809
Increased
972
Reduced
1,047
Closed
744
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.35B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$2.85B |
| 3 |
Eli Lilly
LLY
|
+$999M |
| 4 |
Coca-Cola
KO
|
+$685M |
| 5 |
Broadcom
AVGO
|
+$616M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.38B |
| 2 |
Apple
AAPL
|
+$1.12B |
| 3 |
Netflix
NFLX
|
+$678M |
| 4 |
Boston Scientific
BSX
|
+$671M |
| 5 |
Cencora
COR
|
+$627M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.19% |
| 2 | Consumer Discretionary | 12.77% |
| 3 | Healthcare | 10.45% |
| 4 | Financials | 7.74% |
| 5 | Communication Services | 5.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
Open Text
OTEX
$6.02B
| $971K | ﹤0.01% |
29,800
+20,900
| +235% | +$745K |
|
1927
Business First Bancshares
BFST
$1.05B
| $965K | ﹤0.01% |
36,930
+16,130
| +78% | +$408K |
|
1928
Tootsie Roll Industries
TR
$3.02B
| $965K | ﹤0.01% |
+27,133
| New | +$1.03M |
|
1929
TTEC Holdings
TTEC
$77.4M
| $964K | ﹤0.01% |
267,814
-31,020
| -10% | -$105K |
|
1930
Vroom Inc
VRM
$54M
| $964K | ﹤0.01% |
48,471
| – | – |
|
|
DVS
1931
DELISTED
Dolly Varden Silver Corp
DVS
| $961K | ﹤0.01% |
217,912
+94,109
| +76% | +$413K |
|
1932
ReposiTrak
TRAK
$158M
| $960K | ﹤0.01% |
77,617
+57,371
| +283% | +$815K |
|
1933
Upwork
UPWK
$1.08B
| $952K | ﹤0.01% |
48,049
-144,781
| -75% | -$2.66M |
|
|
SLN
1934
Silence Therapeutics
SLN
$660M
| $947K | ﹤0.01% |
155,680
+72,461
| +87% | +$464K |
|
1935
Karyopharm Therapeutics
KPTI
$45.1M
| $945K | ﹤0.01% |
128,451
| – | – |
|
1936
Karooooo
KARO
$1.97B
| $944K | ﹤0.01% |
20,755
-21,382
| -51% | -$1M |
|
1937
Agnico Eagle Mines
AEM
$91.3B
| $942K | ﹤0.01% |
+5,555
| New | +$934K |
|
1938
Ring Energy
REI
$349M
| $937K | ﹤0.01% |
+1,077,569
| New | +$1.03M |
|
1939
CALL
Expedia Group
EXPE
$39.4B
| $935K | ﹤0.01% |
+3,300
| New | +$815K |
|
1940
Thryv Holdings
THRY
$96.9M
| $933K | ﹤0.01% |
+154,223
| New | +$1.22M |
|
1941
Elicio Therapeutics
ELTX
$82.7M
| $933K | ﹤0.01% |
117,200
+30,667
| +35% | +$278K |
|
1942
Farmers & Merchants Bancorp
FMAO
$486M
| $932K | ﹤0.01% |
37,696
+15,211
| +68% | +$379K |
|
1943
Bath & Body Works
BBWI
$3.76B
| $930K | ﹤0.01% |
46,314
-1,376,627
| -97% | -$30.4M |
|
1944
Companhia Siderúrgica Nacional
SID
$1.19B
| $930K | ﹤0.01% |
+580,998
| New | +$944K |
|
|
TBRG
1945
DELISTED
TruBridge
TBRG
| $929K | ﹤0.01% |
+42,088
| New | +$881K |
|
1946
Recursion Pharmaceuticals
RXRX
$1.78B
| $927K | ﹤0.01% |
226,609
+148,350
| +190% | +$735K |
|
|
LNW
1947
DELISTED
Light & Wonder
LNW
| $926K | ﹤0.01% |
+8,985
| New | +$707K |
|
1948
Curtiss-Wright
CW
$25.4B
| $926K | ﹤0.01% |
1,680
-1,620
| -49% | -$904K |
|
|
VENU
1949
Venu Holding Corp
VENU
$121M
| $925K | ﹤0.01% |
+109,888
| New | +$1.22M |
|
1950
Primis Financial Corp
FRST
$413M
| $923K | ﹤0.01% |
+66,372
| New | +$751K |
|
Similar funds
Marshall Wace's Q4 2025 Portfolio in Review
As of Q4 2025, Marshall Wace held 3,643 positions worth $110B, up 11% from $98.6B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Marshall Wace deployed $8.89B of net new capital in Q4 2025, opening 809 new positions and adding to 972 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 4,580,704 shares worth $2.87B.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Microsoft, an estimated $1.38B trimmed.
- Marshall Wace's largest Q4 2025 buy was Vanguard S&P 500 ETF: 4,580,704 shares worth $2.87B.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $3.35B increase.
- Marshall Wace's biggest Q4 2025 reduction was Microsoft, cutting an estimated $1.38B.
- Marshall Wace fully exited Ares Management in Q4 2025, selling an estimated $146M.
- Marshall Wace's ten largest holdings make up 35% of its $110B portfolio in Q4 2025.
- Marshall Wace opened 809 new positions and closed 744 in Q4 2025.
- Marshall Wace's portfolio value rose 11% quarter-over-quarter to $110B.
Based on Marshall Wace's 13F filing for Q4 2025, filed 13 Feb 2026.